Literature DB >> 35356984

ROR2 Downregulation Activates the MSX2/NSUN2/p21 Regulatory Axis and Promotes Dental Pulp Stem Cell Senescence.

Xin He1, Zhan Yang2, Xiao-Yang Chu3, Yun-Xia Li4, Biao Zhu4, Yan-Xia Huang1, Wei Wang1, Chun-Yan Gao1, Xu Chen1, Chun-Yan Zheng1, Kai Yang5, Dong-Liang Zhang1.   

Abstract

Cellular senescence severely limits the research and the application of dental pulp stem cells (DPSCs). A previous study conducted by our research group revealed a close implication of ROR2 in DPSC senescence, although the mechanism underlying the regulation of ROR2 in DPSCs remains poorly understood so far. In the present study, it was revealed that the expression of the ROR2-interacting transcription factor MSX2 was increased in aging DPSCs. It was demonstrated that the depletion of MSX2 inhibits the senescence of DPSCs and restores their self-renewal capacity, and the simultaneous overexpression of ROR2 enhanced this effect. Moreover, MSX2 knockdown suppressed the transcription of NOP2/Sun domain family member 2 (NSUN2), which regulates the expression of p21 by binding to and causing the 5-methylcytidine methylation of the 3'- untranslated region of p21 mRNA. Interestingly, ROR2 downregulation elevated the levels of MSX2 protein, and not the MSX2 mRNA expression, by reducing the phosphorylation level of MSX2 and inhibiting the RNF34-mediated MSX2 ubiquitination degradation. The results of the present study demonstrated the vital role of the ROR2/MSX2/NSUN2 axis in the regulation of DPSC senescence, thereby revealing a potential target for antagonizing DPSC aging.
© The Author(s) 2022. Published by Oxford University Press.

Entities:  

Keywords:  MSX2; NSUN2; ROR2; dental pulp stem cell; senescence

Mesh:

Substances:

Year:  2022        PMID: 35356984     DOI: 10.1093/stmcls/sxab024

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  1 in total

Review 1.  The two facets of receptor tyrosine kinase in cardiovascular calcification-can tyrosine kinase inhibitors benefit cardiovascular system?

Authors:  Ainun Nizar Masbuchin; Mohammad Saifur Rohman; Ping-Yen Liu
Journal:  Front Cardiovasc Med       Date:  2022-09-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.